Tilray Brands Reports Q2 Fiscal 2026 Financial Results
NEW YORK – Tilray Brands Inc. posted net revenue of $217.5 million for its fiscal second quarter ended November 30, 2025, marking the company's highest quarterly figure to date and edging up 3% from $211 ...
Helus Pharma Rings Nasdaq Bell Post-Cybin Rebrand
TORONTO – Helus Pharma Inc., rebranded from Cybin Inc., opened trading on the Nasdaq Global Market under the ticker symbol $HELP, marking a shift from the NYSE American where it previously traded as $CYBN. The ...
Who Will Decide Cannabis Legalization? The Math Will.
LOS ANGELES -For decades, Cannabis reform in the United States has moved unevenly—state by state, ballot by ballot, crisis by crisis. On paper, federal prohibition still stands, and national politics remain polarized. But economically and ...
From $700 Million Unicorn to Fire-Sale Exit: What the Eaze–Vireo Deal Says About California Cannabis
LOS ANGELES- When Eaze first burst onto the scene, it was marketed as the “Uber of Cannabis”—a tech-enabled delivery platform that promised to professionalize and scale legal access across California. At its peak, Eaze ...
Arizona Ballot Measure Targets Cannabis Retail Shutdown
PHOENIX – A conservative-backed campaign in Arizona has launched an effort to roll back key elements of the state's adult-use Cannabis program, filing a ballot initiative last month that would shutter licensed dispensaries and end ...
Fluent Offloads Pennsylvania Dispensaries
NEW YORK – Fluent Corp. has finalized the sale of its three Pennsylvania dispensaries to HIVE Holdings Inc. for $12.5 million in cash, marking a deliberate shift toward debt reduction and operational efficiency. The deal ...
Medicare’s CBD Shift Signals Validation—But a Looming Hemp Ban Clouds the Path for Seniors
NEW YORK- For decades, seniors managing chronic pain, inflammation, anxiety, or sleep disruption have relied largely on pharmaceuticals—often with long lists of side effects. That landscape is starting to change. Medicare is preparing to recognize cannabidiol ...
Fluent Offloads Pennsylvania Dispensaries
NEW YORK – Fluent Corp. has finalized the sale of its three Pennsylvania dispensaries to HIVE Holdings Inc. for $12.5 million in cash, marking a deliberate shift toward debt reduction and operational efficiency. The deal ...
Medicare’s CBD Shift Signals Validation—But a Looming Hemp Ban Clouds the Path for Seniors
NEW YORK- For decades, seniors managing chronic pain, inflammation, anxiety, or sleep disruption have relied largely on pharmaceuticals—often with long lists of side effects. That landscape is starting to change. Medicare is preparing to recognize cannabidiol ...
DEA Increases Psychedelics Production Quotas for 2026
WASHINGTON – The Drug Enforcement Administration has approved expanded production limits for key psychedelics, setting the stage for increased scientific inquiry into substances like psilocybin and DMT next year. In a final order published Monday ...
Psychedelics Advance in Federal Arena as Trials and Policies Align
LOS ANGELES – Federal health officials under the Trump administration have begun to signal stronger backing for psychedelic therapies, setting the stage for possible FDA approvals of MDMA and psilocybin treatments within the next 18 ...
RESPECT: House Lawmakers Introduce Cannabis Equity Resolution
WASHINGTON – A group of eight House lawmakers, led by members of the Congressional Cannabis Caucus, filed a resolution aimed at bolstering fair access to the burgeoning Cannabis sector for communities long sidelined by federal ...
Bipartisan Measure Targets Barriers to Psychedelic Therapies for Terminal Patients
WASHINGTON – A group of House and Senate lawmakers from both parties unveiled legislation to permit physicians to deliver Schedule I substances, including MDMA and psilocybin, to individuals grappling with terminal illnesses or severe mental ...
Curaleaf Opens 70th Dispensary in Florida
STAMFORD – Curaleaf Holdings Inc. added its 70th medical Cannabis dispensary in Florida, targeting patients along the Space Coast with a new location in Cape Canaveral. The store, set for a grand opening on December ...
Aurora Partners with Leafio to Expand Medical Cannabis Reach in Australia
EDMONTON – Aurora Cannabis Inc. disclosed a new wholesale distribution agreement with Leafio, the supply chain arm of Montu Australia, positioning the Canadian producer to channel more of its medical Cannabis lineup into clinics and ...
Curaleaf Secures Virginia Foothold with Purchase of Cannabist Assets
STAMFORD – Curaleaf Holdings, Inc. has entered into an agreement to purchase key Cannabis operations in Virginia from The Cannabist Co. Holdings Inc. for $110 million, marking a calculated move into one of the East ...
Virginia Panel Outlines Path to Regulated Cannabis Sales in 2026
RICHMOND – Members of Virginia's Joint Commission to Oversee the Transition of the Commonwealth into a Cannabis Retail Market presented a series of amendments to create a licensed system for adult-use Cannabis sales, targeting a ...
Texas Regulator Awards Verano Conditional License to Operate in State’s Medical Cannabis Market
AUSTIN – The Texas Department of Public Safety has issued a conditional license to Verano Texas, LLC, a subsidiary of Verano Holdings Corp., paving the way for the MSO to pursue cultivation, processing, and retail ...
Sensi Brands Secures Major Cultivation Site in Bid for Overseas Expansion
RICHMOND HILL – Sensi Brands Inc. completed its purchase of Maricann Inc., gaining control of a sprawling production facility tailored for export markets. The deal, the company's biggest to date, centers on a 100-acre campus ...
High Tide Launches Europe’s First Canna Cabana Store in Berlin
BERLIN – High Tide Inc., the Calgary-based Cannabis retailer known for its discount club model, has cut the ribbon on its inaugural European outpost, a Canna Cabana store in central Berlin that sells accessories and ...
Conservative Think Tank Advocates Federal Cannabis Labeling Standards to Address State Disparities
WASHINGTON – A prominent conservative policy group has called for federal guidance on Cannabis product warnings, pointing to stark differences in state regulations that leave consumers with inconsistent information on health risks. The American Enterprise ...
Psyence BioMed Ventures into Psilocybin’s Role in Aging Research
NEW YORK – Psyence BioMedical Ltd. disclosed its entry into longevity science with a new program probing psilocybin's influence on key aging indicators. The initiative, conducted alongside South African academics, marks the company's first foray ...
Kenyan MP Advocates for Regulated Cannabis Framework
NAIROBI – Peter Kalerwa Salasya, the outspoken member of Parliament for Kenya's Mumias East constituency, has ignited fresh debate on Сannabis policy by urging the government to pursue legalization under strict controls. Salasya highlighted the ...
OPINION: The Looming Federal Clampdown on THC Drinks and Hemp-Derived Edibles: What It Means for the Industry
NEW YORK- The quiet addition of a single paragraph in November’s federal shutdown bill has sent shockwaves through one of the fastest-growing segments of U.S. Cannabis: hemp-derived THC beverages and edibles. Unless Congress intervenes, a ...
Tilray Executes 1-for-10 Reverse Stock Split to Trim Shares and Cut Costs
NEW YORK – Tilray Brands Inc. confirmed it will carry out a 1-for-10 reverse stock split on its common shares, a step shareholders greenlit back in June to help the company meet Nasdaq listing standards ...
New York State OCM Updates Medical Cannabis Program, Expands Access for Out-of-State Patients
ALBANY – Governor Kathy Hochul signed a bill into law that extends New York's medical Cannabis program to patients certified in other states, marking the most substantial revision to the initiative since its 2016 launch. ...
New Brunswick Government Bets on Organigram with $2M Grant
MONCTON – Organigram Global Inc. has secured $2 million in provincial funding to support a $9.3 million project aimed at revamping its flagship cultivation site here. The upgrade, which targets lighting systems across 75 grow ...
Jazz Pharmaceuticals: The Medical Cannabis Insider Nearing $1B Milestone
DUBLIN – Jazz Pharmaceuticals reported a 20% jump in Q3 2025 sales for its cannabidiol-based epilepsy drug Epidiolex®, pushing the product's YTD revenue past $772 million and underscoring the company's steady position in the medical ...
Medicare Explores CBD Coverage for Seniors
WASHINGTON – The Centers for Medicare & Medicaid Services (CMS) is set to roll out a pilot program that could extend coverage to cannabidiol (CBD) treatments for certain older Americans, marking a cautious step by ...
How to Make the Most of MJBizCon? Take Full Advantage of LinkedIn
LOS ANGELES- Each year, the global Cannabis industry converges on Las Vegas for MJBizCon Dec 2-5 in the Las Vegas Convention Center—a concentrated, high-value moment where operators, investors, executives, retailers, lenders, lawyers, accountants, manufacturers, and ...
New Jersey Assembly Panel Clears Path for Psilocybin Therapy Program
TRENTON – New Jersey lawmakers advanced a bill that would allow supervised access to psilocybin for adults facing certain health challenges, establishing a regulated psilocybin therapy framework approved by the Assembly Health Committee. Assemblymember Anthony ...
Week in Review: Cannabis & Psychedelics Industry Highlights
LOS ANGELES – Operators and investors in Cannabis and Psychedelics faced a week of sharp contrasts. Federal action ended the longest government shutdown on record, yet it delivered a body blow to hemp-derived products that ...
Europe Advances Psychedelic Medicine with Targeted Approvals in Three Nations
BERLIN – Switzerland's long-standing framework for psychedelic treatments has set a course for its neighbors, as Germany and the Czech Republic roll out their own programs to address stubborn mental health conditions. These steps mark ...
Tilray Updated Investor Presentation Detailing Diversification Strategy
NEW YORK – Tilray Brands Inc. laid out its broadened ambitions in a new Investor Presentation. The document maps a course for the company to solidify its place as a consumer goods player, blending Cannabis ...
Argent BioPharma Secures AU$11M Facility to Finalize AusCann Assets Purchase
SYDNEY – Argent BioPharma Ltd., a developer of cannabinoid-based treatments for neurological disorders, has arranged an AU$11 million convertible debt facility to close its pending acquisition of key assets from the defunct AusCann Group Holdings ...
